About SamanTree Medical

SamanTree Medical proposes a breakthrough innovation for checking complete tumor removal during surgery: the Histolog™ Scanner. This novel imaging modality is a direct support during cancer surgery to achieve the common goal of improving patient quality of life by decreasing rates of reoperation.

The team is fully dedicated to bringing the Gold Standard in the operating room, enabling margin assessment, in real time, at the histological detail.

SamanTree Medical SA was founded in December 2014 and is a spin-off of the EPFL (Ecole Polytechnique Fédérale de Lausanne).

Following the promising clinical results achieved with its CE mark device, SamanTree Medical is currently raising fund for developing its commercial operations.

Please have a quick look at the company and its product the Histolog™ Scanner in this video, shot at the occasion of the ceremony PERL 2018 (Prix Entreprendre Region Lausanne) – SamanTree winner of the Trophee.

©Lausanne Région – La Prod

Team

bastien rachet
Bastien Rachet, PhD
CEO, Founder

etienne shaffer
Etienne Shaffer, PhD
CTO, Founder

frederic schmitt
Frederic Schmitt, PhD
Clinical Application

diego joss
Diego Joss
Hardware/Electronics 

jonathan pirolet
Jonathan Pirolet
Mechanical Design

andrey naumenko
Andrey Naumenko, PhD
Software Architecture

Board of Directors & Management

Jan Dekker is a director of a number of private companies. Jan began his career at Philips Corporation where he worked from 1973 to 1981. He then joined KPMG Meijburg & Co, where he became Senior Partner in the International Tax Practice.

Perry is an international business executive with a strong track record of successful business management, innovation and strategy in large/mature businesses and start-ups. He currently is CEO and Founder of 21st Century Business Growth Advisors B.V. Prior this, he was, as CEO of Philips Corporate Venturing, reporting directly to Philips Board of Management.
linkedin

Malgosia has been active in the field of medical devices for the last 25+ years, and brings extensive experience in sales, marketing, training and regulatory in Europe, the USA and Asia. Malgosia held various senior management positions with companies like Medtronic, and Johnson & Johnson, as well as with fast growing start-up companies like Computer Motion Sensimed and KB Medical.
linkedin

Bastien is co-founder, and current CEO & Director of SamanTree Medical. He has more than 8 years of experience in technological and business development in the fields of medical devices and microscopy. He holds a MSc degree in Optics, Physics and Engineering from Institut d’Optique Graduate School (France) and a PhD by CEA-Leti (France).
linkedin

Etienne is co-founder and CTO of the company. He has over 10 years of experience in development of advanced microscopy techniques and 5 years of experience in entrepreneurship. Etienne holds a BSc degree in Physics and a MSc degree in Electrical Engineering, both from Université de Sherbrooke (Canada), as well as a PhD degree in Photonics from EPFL (Lausanne, Switzerland).
linkedin

Advisors

Jean-Marc brings to SamanTree Medical his extensive experience in international growth management and financing.
Formerly executive with Medtronic, Lysis, Sensimed, KB Medical, he is active since 2003 as an executive, director and consultant for innovative high-tech companies. Jean-Marc spent 8 years as founder and CEO of Sensimed, where he raised over $50M in equity and led the company to develop its radically innovative technology into a robust, validated industrialized product. He then took the position of CEO with KB Medical, a company active in providing robotic assistance for highly accurate spinal surgery procedures, led the company to a successful trade sale with Globus Medical. Since September 2017, Jean-Marc joined the Swiss neurotechnology unicorn MindMaze as Chief Operating Officer. He is also chairman of the strategic advisory board of Berdoz Optic, consultant and financial expert with Platinn and CTI start-up, and active in various other organizations.

Guido is acting as Chief Commercial Officer ad interim for SamanTree Medical and focuses on the market launch planning, execution and strategic partnerships.
He is a senior commercial executive with many years of experience in revenue growth and innovation in medical devices, IVD/diagnostics, Healthcare Informatics and Imaging. Guido has built, scaled up and managed global operations; created compelling, differentiating strategies and value propositions; developed and launched new products; built new channels; and closed large international sales deals of more than €10 million. Guido has deep experience in commercializing disruptive innovations and in growing and professionalizing organizations.
The past ten years, he co-founded, built and managed the Philips Digital Pathology venture resulting in tens of millions of Euro revenue and he founded an online marketplace for innovative genetic diagnostic tests as part of myTomorrows.

Marius is Surgical Pathologist and brings to SamanTree Medical his expertise in digital pathology.
Marius graduated as an MD at the Erasmus University in Rotterdam in 1979. After his training at the University of Groningen he was registered as a surgical pathologist in December 1982. He was consultant pathologist at Leiden University and later at the institute of public health in Friesland where he started to explore the possibilities of digital pathology. From 1996 until December 2015 he chaired the department of surgical pathology of the Atrium Medical center in Heerlen and introduced flow cytometry on solid tumors, speech recognition as well as digital pathology as part of daily routine. In 2015 he founded Nap Pathology Consultance to further explore the possibilities of digital pathology across geographical and language borders. Marius has published several scientific papers about the transition from conventional light microscopy to digital pathology and is a frequent speaker at national and international conferences.

Investment Opportunities

SamanTree Medical SA is a private corporation located in Switzerland.

Investment opportunities are currently available to investors – including family offices, investment holdings, HNWI and venture capital firms.  SamanTree Medical intends to begin commercializing its proprietary Histolog system in 2018. Additional information is available.

We welcome inquiries from investors who want to consider how they can profit from this opportunity.

To learn more, please contact our corporate finance advisor:
Carl Stiewe, Managing Director
INNOVAND Consulting GmbH
Tel. +49-4171-782380
stiewe[at]innovand.com

innovand consulting

Contact Us

SamanTree Medical SA

Rue de Genève 88b
1004 Lausanne
Switzerland
Phone number: +41 21 625 09 40
info@samantree.com